NEW YORK (GenomeWeb News) – Alnylam Pharmaceuticals announced today that it has granted a non-exclusive, worldwide license to Shanghai GenePharma, allowing the Chinese siRNA supplier to manufacture and sell RNAi products and services covered by Alnylam-owned patents for research purposes.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.